N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142883 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142884 |
| CAS No | NA |
| Mol.F. | C18H22N2O5 |
| Mol.Wt. | 346.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142885 |
| CAS No | NA |
| Mol.F. | C23H28N2O11 |
| Mol.Wt. | 508.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142886 |
| CAS No | NA |
| Mol.F. | C12H13N3O6 |
| Mol.Wt. | 295.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142887 |
| CAS No | NA |
| Mol.F. | C4H6N6O2 |
| Mol.Wt. | 170.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142888 |
| CAS No | NA |
| Mol.F. | C14H11N7O4 |
| Mol.Wt. | 341.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142889 |
| CAS No | NA |
| Mol.F. | C26H23N13O8 |
| Mol.Wt. | 645.55g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142890 |
| CAS No | NA |
| Mol.F. | C7H5ClN6O2 |
| Mol.Wt. | 240.61g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142891 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142892 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142893 |
| CAS No | NA |
| Mol.F. | C31H30N10O11 |
| Mol.Wt. | 718.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142894 |
| CAS No | NA |
| Mol.F. | C23H23N13O7 |
| Mol.Wt. | 593.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142895 |
| CAS No | NA |
| Mol.F. | C19H16N8O7 |
| Mol.Wt. | 468.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142896 |
| CAS No | NA |
| Mol.F. | C30H29ClN10O9 |
| Mol.Wt. | 709.07 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142897 |
| CAS No | NA |
| Mol.F. | C21H26N8O7 |
| Mol.Wt. | 502.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142898 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |